{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE SENATE OF THE UNITED STATES"}, "#text": "\n\t\t", "congress": {"#tail": "\n    ", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "S. 2722"}, "official-title": {"#tail": "\n\t", "#text": "To facilitate identification and dissemination of evidence-informed recommendations for\n\t\t\t addressing maternal addiction and neonatal abstinence syndrome and to\n\t\t\t provide for studies with respect to neonatal abstinence syndrome. "}, "session": {"#tail": "\n\t\t", "#text": "2d Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "II"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20140731", "#text": "July 31, 2014"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "sponsor": {"#tail": " introduced the following bill; which was read twice and referred to the ", "#text": "Mr. McConnell", "@name-id": "S174"}, "committee-name": {"#tail": "\n      ", "@committee-id": "SSHR00", "#text": "Committee on Health, Education, Labor, and Pensions"}}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-Senate", "@dms-id": "A1", "@public-private": "public", "legis-body": {"#tail": "\n", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "act", "#text": "Protecting Our Infants Act of 2014", "@value": "Protecting Our Infants Act of 2014", "@proposed": "true"}, "#text": "\n            "}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the\n\t\t  ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n\t\t\t", "#text": "Short title"}, "#text": "\n      ", "@id": "S1"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Evidence-informed recommendations with respect to maternal addiction and neonatal abstinence\n\t\t\t syndrome"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (referred to in this section as the ", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}, "#text": "The ", "quote": {"#tail": ") shall coordinate and facilitate the\u2014", "#text": "Secretary"}}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In general"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n        ", "#text": "identification and compilation of evidence-informed recommendations for physicians, nurses, and\n\t\t\t hospital facilities with respect to neonatal abstinence syndrome; and"}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "id40c6311627624848b5d62333edec5b31", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n          ", "#text": "identification of any gaps, as appropriate, in such evidence-informed recommendations that may\n\t\t\t require additional research or analysis with respect to\u2014"}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "#text": "\n          ", "@id": "id2913711b03b149a7b7299f095246b55c", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n          ", "#text": "screening and intervention for maternal substance abuse, including the misuse or abuse of\n\t\t\t prescription drugs in women of childbearing age and pregnant women;"}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "id51a9599ebe86484d8a1e3f576e7a947f", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n          ", "#text": "treatment for pregnant and post\u00adpar\u00adtum women with a substance use disorder, including the misuse\n\t\t\t or\n\t\t\t abuse of prescription drugs;"}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "id64a8ddcdeb8748daae44fa5a42087709", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n          ", "#text": "screening of infants for neonatal abstinence syndrome and for the risk of developing neonatal\n\t\t\t abstinence syndrome;"}, "enum": {"#tail": "\n            ", "#text": "(C)"}, "@id": "id246c969053434cc8b8942a72c0fee1ad", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n          ", "#text": "treatment for infants with neonatal abstinence syndrome, including evidence-informed\n\t\t\t recommendations surrounding evaluation and treatment with pharmacological\n\t\t\t and non-pharmacological interventions; and"}, "enum": {"#tail": "\n            ", "#text": "(D)"}, "@id": "idb7636aad49fe4520989b6937d7c2483a", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n          ", "#text": "ongoing treatment, services, and supports for postpartum women with a substance use disorder,\n\t\t\t including misuse or abuse of prescription drugs, and infants and children\n\t\t\t with neonatal abstinence syndrome."}, "enum": {"#tail": "\n            ", "#text": "(E)"}, "@id": "id8e013c2fb5874ac293de6c4a7f99b0bf", "#text": "\n            "}]}], "#text": "\n        ", "@id": "id2F44C0465B1B4D6498C23DE2233E95AC"}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall consider input from stakeholders, such as\n\t\t\t health professionals, public health officials, and law enforcement.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "In carrying out subsection (a), the "}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Input"}, "#text": "\n        ", "@id": "id32da2f0e0945436ea76e1325d190e45c"}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall disseminate to appropriate stakeholders in States and local communities the\n\t\t\t evidence-informed recommendations identified under subsection (a).", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The "}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Dissemination of information"}, "#text": "\n        ", "@id": "id3f9d0e4782ff493e9cda4c26a0eeb74a"}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall conduct a study to evaluate\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The "}, "enum": {"#tail": "\n        ", "#text": "(d)"}, "header": {"#tail": "\n        ", "#text": "Addressing Research Needs for Maternal Addiction and Neonatal Abstinence Syndrome"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n        ", "#text": "factors related to the increased prevalence of maternal opiate misuse and abuse;"}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "idF774EDFF5665466EAF2805D1C1A3C622", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n          ", "#text": "factors related to maternal misuse and abuse of opiates, including\u2014"}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "#text": "\n          ", "@id": "idC9F019CF578F424E94F3840692BC6EBD", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n          ", "#text": "barriers to identifying and treating maternal misuse and abuse of opiates; and"}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "idB1D76E0042074DAE81A45BF3DDA27722", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n          ", "#text": "the most effective prevention and treatment strategies for pregnant women and other women of\n\t\t\t childbearing age who are at risk for or dependent on opiates; and"}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "idED2DC55469974687AD9E67C1E26E29F3", "#text": "\n            "}]}, {"#tail": "\n      ", "text": {"#tail": "\n          ", "#text": "factors related to neonatal abstinence syndrome, including\u2014"}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "#text": "\n          ", "@id": "id8287DB8B395346BAB2CA5FDE3EA7F106", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n          ", "#text": "epidemiological studies concerning neonatal abstinence syndrome;"}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "idAB76CB7F7D6B497C9B264DD0A821090C", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n          ", "#text": "the most effective methods to diagnose and treat neonatal abstinence syndrome; and"}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "id78E9D1435D1E45558917248F6FCE02D0", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n          ", "#text": "the long-term effects of neonatal abstinence syndrome and the need for a longer-term study on\n\t\t\t infants and children at risk for developing neonatal abstinence syndrome\n\t\t\t or diagnosed with neonatal abstinence syndrome."}, "enum": {"#tail": "\n            ", "#text": "(C)"}, "@id": "idBF7691DF980B4CDC8019EAC4E58477C4", "#text": "\n            "}]}], "#text": "\n        ", "@id": "id00c48777771042f8b3c9de74162dcb30"}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall provide to the\n\t\t\t ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and the ", "@entity-type": "committee", "#text": "Committee on Health, Education, Labor, and Pensions of the\n\t\t\t Senate", "@entity-id": "SSHR00"}, {"#tail": " the findings from the study under subsection (d) and a\n\t\t\t report that identifies the gaps in evidence-informed\n\t\t\t recommendations that require additional research or analysis, and priority\n\t\t\t areas for additional research.", "@entity-type": "committee", "#text": "Committee on Energy and Commerce of the House of\n\t\t\t Representatives", "@entity-id": "HIF00"}], "#text": "Not later than 1 year after the date of enactment of this Act, the "}, "enum": {"#tail": "\n        ", "#text": "(e)"}, "header": {"#tail": "\n        ", "#text": "Report"}, "#text": "\n        ", "@id": "idD1C7E5D95FDB470DB74F4C55360095EA"}], "#text": "\n      ", "@id": "id737CDE638DCB4FFE884868D8C0428E52"}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", acting through the ", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}, {"#tail": ", shall\n\t\t\t provide technical assistance to States to improve the availability and\n\t\t\t quality of data collection and surveillance activities regarding neonatal\n\t\t\t abstinence syndrome, including\u2014", "@entity-type": "federal-body", "#text": "Director of the Centers for Disease\n\t\t\t Control and Prevention", "@entity-id": "7523"}], "#text": "The ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n      ", "#text": "Improving data on neonatal abstinence syndrome"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "incidence and prevalence of neonatal abstinence syndrome;"}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "id69ed3b809dbf4f258efa922215df46a0", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "the identification of causes for neonatal abstinence syndrome, including new and emerging trends;\n\t\t\t and"}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "@id": "id3575fc0f0d034029a402674dfc64cbd2", "#text": "\n        "}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "#text": "the identification of demographics and other relevant information associated with neonatal\n\t\t\t abstinence syndrome."}, "enum": {"#tail": "\n        ", "#text": "(3)"}, "@id": "idabb20d030a274ada98048befa8cc3c2c", "#text": "\n        "}], "#text": "\n      ", "@id": "id8debdcb3e59349e1b75ff26cc1809e69"}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " that the ", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, {"#tail": " should continue\n\t\t\t research with respect to pain management, including for women of\n\t\t\t childbearing age.", "@entity-type": "federal-body", "#text": "Director of the National Institutes of Health", "@entity-id": "7529"}], "#text": "It is the sense of ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "4."}, "header": {"#tail": "\n      ", "#text": "Pain management alternatives"}, "#text": "\n      ", "@id": "idf5fab6d49a92406992111bb0e9ce9533"}, {"#tail": "\n  ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall conduct a study evaluating\u2014", "@entity-type": "federal-body", "#text": "Comptroller General of the\n\t\t\t United States", "@entity-id": "0500"}, "#text": "Not later than 1 year after the date of enactment of this Act, the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "5."}, "header": {"#tail": "\n      ", "#text": "GAO study"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "the availability and effectiveness of federally facilitated substance abuse treatment programs for\n\t\t\t pregnant women and their children;"}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "id631de76d5c86427ca74520a5b1954173", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "#text": "the availability and effectiveness of Federal programs that encourage State adoption and\n\t\t\t implementation of programs to ensure\u2014"}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "#text": "\n        ", "@id": "id962c28bf09164737811265edc4dfbada", "subparagraph": [{"#tail": "\n        ", "text": {"#tail": "\n        ", "#text": "the safety and health of mothers who have a substance use disorder; and"}, "enum": {"#tail": "\n          ", "#text": "(A)"}, "@id": "idf28442c966684b32a2d6559d10145298", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "#text": "the safety and health of children with neonatal abstinence syndrome;"}, "enum": {"#tail": "\n          ", "#text": "(B)"}, "@id": "id45a46b8a827b4956bf85853b5b82aa2f", "#text": "\n          "}]}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "the effectiveness of Federal data systems and surveillance programs used to monitor or track drug\n\t\t\t utilization and resulting trends, including whether information on\n\t\t\t neonatal abstinence syndrome is incorporated into such data systems; and"}, "enum": {"#tail": "\n        ", "#text": "(3)"}, "@id": "idaa326058d12c465fb9c6771dd50c65a6", "#text": "\n        "}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "the identification of the use of all discretionary funds to address maternal substance abuse,\n\t\t\t including the misuse and abuse of prescription drugs."}, "enum": {"#tail": "\n        ", "#text": "(4)"}, "@id": "id64419d65f6c242659222d17c055ddf35", "#text": "\n        "}], "#text": "\n      ", "@id": "ide752710d80744be38e570b763879d527"}], "#text": "\n\t\t"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2014-07-31"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 S2722 IS: Protecting Our Infants Act of 2014"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. Senate"}, "#text": "\n"}, "#text": "\n"}}}